Cdx4 and menin co-regulate Hoxa9 expression in hematopoietic cells

PLoS ONE

Volumn 1, Issue 1, 2006, Pages

  Yan, Jizhou ^a   Chen, Ya Xiong ^a   Desmond, Angela ^a   Silva, Albert ^a   Yang, Yuqing ^a   Wang, Haoren ^a   Hua, Xianxin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; METHIONINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX4; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG; CDX4 PROTEIN, MOUSE; DNA; HISTONE; HOMEODOMAIN PROTEIN; MEN1 PROTEIN, MOUSE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCUS; HEMATOPOIETIC CELL; IN VIVO STUDY; LEUKEMIA CELL LINE; METHYLATION; NONHUMAN; PROTEIN BINDING; REGULATORY SEQUENCE; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CHEMISTRY; CHROMATIN; EXPERIMENTAL LEUKEMIA; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; METABOLISM; MOUSE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TRANSFORMED; CHROMATIN; DNA; GENES, REPORTER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HISTONES; HOMEODOMAIN PROTEINS; LEUKEMIA, EXPERIMENTAL; MICE; MULTIGENE FAMILY; MUTAGENESIS, SITE-DIRECTED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTIONAL ACTIVATION;

EID: 34250174458     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000047     Document Type: Article

References (59)

1. Magli MC, Largman C, Lawrence HJ (1997) Effects of HOX homeobox genes in blood cell differentiation. J Cell Physiol 173: 168-177.
2. Owens BM, Hawley RG (2002) HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20: 364-379.
3. Ayton PM, Cleary ML (2001) Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20: 5695-5707.
4. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, et al. (1999) The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. Embo J 18: 3564-3574.
5. Look AT (1997) Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1064.
6. Sorensen PH, Chen CS, Smith FO, Arthur DC, Domer PH, et al. (1994) Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 93: 429-437.
7. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-407.
8. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6: 1177-1183.
9. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, et al. (2004) Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13: 587-597.
10. Lemmens IH, Forsberg L, Pannett AA, Meyen E, Piehl F, et al. (2001) Menin interacts directly with the homeobox-containing protein Pem. Biochem Biophys Res Commun 286: 426-431.
11. Lin SY, Elledge SJ (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881-889.
12. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, et al. (2004) Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24: 5639-5649.
13. Chen YX, Yan J, Keeshan K, Tubbs AT, Wang H, et al. (2006) The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc Natl Acad Sci U S A 103: 1018-1023.
14. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, et al. (2005) The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis. Cell 123: 207-218.
15. Pollard SL, Holland PW (2000) Evidence for 14 homeobox gene clusters in human genome ancestry. Curr Biol 10: 1059-1062.
16. Davidson AJ, Ernst P, Wang Y, Dekens MP, Kingsley PD, et al. (2003) cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature 425: 300-306.
17. Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, et al. (2005) Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106: 3988-3994.
18. Ayton PM, Cleary ML (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 17: 2298-2307.
19. Calvo KR, Sykes DB, Pasillas M, Kamps MP (2000) Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol 20: 3274-3285.
20. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
21. Nakamura T, Largaespada DA, Shaughnessy JD Jr., Jenkins NA, Copeland NG (1996) Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat Genet 12: 149-153.
22. Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, et al. (2003) Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia. Blood 101: 3229-3235.
23. Kumar AR, Hudson WA, Chen W, Nishiuchi R, Yao Q, et al. (2004) Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood 103: 1823-1828.
24. Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, et al. (2005) Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121: 873-885.
25. Schnepp RW, Hou Z, Wang H, Petersen C, Silva A, et al. (2004) Functional interaction between tumor suppressor menin and activator of S-phase kinase. Cancer Res 64: 6791-6796.
26. Deschamps J, van Nes J (2005) Developmental regulation of the Hox genes during axial morphogenesis in the mouse. Development 132: 2931-2942.
27. Cao R, Zhang Y (2004) SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15: 57-67.
28. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039-1043.
29. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, et al. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10: 1107-1117.
30. Dehe PM, Pamblanco M, Luciano P, Lebrun R, Moinier D, et al. (2005) Histone H3 lysine 4 mono-methylation does not require ubiquitination of histone H2B. J Mol Biol 353: 477-484.
31. Morillon A, Karabetsou N, Nair A, Mellor J (2005) Dynamic lysine methylation on histone H3 defines the regulatory phase of gene transcription. Mol Cell 18: 723-734.
32. van Dijk K, Marley KE, Jeong BR, Xu J, Hesson J, et al. (2005) Monomethyl histone H3 lysine 4 as an epigenetic mark for silenced euchromatin in Chlamydomonas. Plant Cell 17: 2439-2453.
33. Lachner M, Jenuwein T (2002) The many faces of histone lysine methylation. Curr Opin Cell Biol 14: 286-298.
34. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, et al. (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10: 1119-1128.
35. Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ (2005) Embryonic stem cellderived hematopoietic stem cells. Proc Natl Acad Sci U S A 102: 19081-19086.
36. Tabaries S, Lapointe J, Besch T, Carter M, Woollard J, et al. (2005) Cdx protein interaction with Hoxa5 regulatory sequences contributes to Hoxa5 regional expression along the axial skeleton. Mol Cell Biol 25: 1389-1401.
37. Gregory PA, Gardner-Stephen DA, Rogers A, Michael MZ, Mackenzie PI (2006) The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene promoter. Pharmacogenet Genomics 16: 527-536.
38. Mendel DB, Khavari PA, Conley PB, Graves MK, Hansen LP, et al. (1991) Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. Science 254: 1762-1767.
39. Wilson DS, Guenther B, Desplan C, Kuriyan J (1995) High resolution crystal structure of a paired (Pax) class cooperative homeodomain dimer on DNA. Cell 82: 709-719.
40. Moore MA (2005) Converging pathways in leukemogenesis and stem cell selfrenewal. Exp Hematol 33: 719-737.
41. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE (1999) Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia 13: 687-698.
42. Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, et al. (1999) Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13: 1993-1999.
43. Berger SL (2002) Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12: 142-148.
44. Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, et al. (2005) A quantitative measurement of the human somatic mutation rate. Cancer Res 65: 8111-8117.
45. Luzzatto L (2001) The mechanisms of neoplastic transformation. Eur J Cancer 37 Suppl 8: S114-117.
46. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, et al. (2005) Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181.
47. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, et al. (2004) Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6: 73-77.
48. Milne TA, Martin ME, Brock HW, Slany RK, Hess JL (2005) Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res 65: 11367-11374.
49. Krogan NJ, Kim M, Tong A, Golshani A, Cagney G, et al. (2003) Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol 23: 4207-4218.
50. Pray-Grant MG, Daniel JA, Schieltz D, Yates JR 3rd, Grant PA (2005) Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 433: 434-438.
51. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
52. Yokoyama A, Kitabayashi I, Ayton PM, Cleary ML, Ohki M (2002) Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100: 3710-3718.
53. Gaunt SJ, Drage D, Trubshaw RC (2005) cdx4/lacZ and cdx2/lacZ protein gradients formed by decay during gastrulation in the mouse. Int J Dev Biol 49: 901-908.
54. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, et al. (2003) Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4: 197-207.
55. Lavau C, Du C, Thirman M, Zeleznik-Le N (2000) Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. Embo J 19: 4655-4664.
56. Lavau C, Luo RT, Du C, Thirman MJ (2000) Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci U S A 97: 10984-10989.
57. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, et al. (2003) Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63: 4204-4210.
58. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B (2001) Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15: 2069-2082.
59. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, et al. (2004) Menin induces apoptosis in murine embryonic fibroblasts. J Biol Chem 279: 10685-10691.